The ascendancy of Viagra and its effect on the drug landscape presents a complex question for investors. While the initial sales data were remarkable, the exclusivity has lapsed, leading to a deluge of off-brand https://roxannossl412861.blog5.net/93372558/the-blue-pill-and-big-pharma-a-speculative-investment